Singlera Genomics, a Shanghai, China- and La Jolla, CA-based non-invasive genetic testing company, raised US$20m in Series A financing.
The round was led by Lilly Asia Ventures, together with Green Pine Capital Partners, CDBI Partners and others.
The company intends to use the funds to expand the development and commercialization of its non-invasive genomic sequencing tests for cancer and other genetic diseases.
Co-founded in July 2014 in San Diego, California by Professor Yuan Gao (Johns Hopkins University), Professor Kun Zhang (University of California at San Diego), Mr. Jiangli Zhang (CEO), Mr. Qiang Liu (COO), Dr. Rui Liu (CTO), Singlera has proprietary technologies in single cell sequencing, DNA methylation and bioinformatics.
Its main products and services include tumor diagnosis and personalized treatment, non-invasive prenatal diagnosis, pre-implantation genetic screening, and other genetic disease diagnosis, as well as customized technology and scientific research services.
FinSMEs
22/08/2016